Healthcare -
Biotechnology - NYSE - US
$ 1.75
-4.37 %
$ 34.1 M
Market Cap
-0.41
P/E
ANVS - CASH FROM OPERATIONS
Cash from Operations ANVS - Annovis Bio, Inc.
-40 M
LAST VALUE
-109.20%
2 YEAR CAGR
-134.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR